| News
Tessera Therapeutics scores $230M to ramp up 'gene writing' tech to cure disease
From FierceBiotech
Tessera Therapeutics is pioneering Gene Writing™—a new genome engineering technology that writes therapeutic messages into the genome to treat diseases at their source.
Our mission is to cure disease by writing in the code of life.
Pioneering a new category of genetic medicine.
The first of its kind, Gene Writing technology can permanently make small and large alterations to the human genome.
No genetic disease target is off-limits. Our Gene Writers can make almost any type of genetic alteration.
Together, we’re driving the future of genetic medicine forward.
| News
Tessera Therapeutics scores $230M to ramp up 'gene writing' tech to cure disease
From FierceBiotech
| News
Programmable genetics gets more cash as Tessera Therapeutics gets a $230 million infusion
From Techcrunch
| News
Tessera Therapeutics Corrals More Than $230 Million for New Genetic Medicines
From WSJ VenturePro